Protest AFR No. 3195-04-100142; Polypeptides; 9817.85.01 Prototype Treatment; Additional U.S. Rule of Interpretation 1(b); Actual Use; 19 CFR 10.134; Classification
Reasoning
Protest AFR No. 3195-04-100142; Polypeptides; 9817.85.01 Prototype Treatment; Additional U.S. Rule of Interpretation 1(b); Actual Use; 19 CFR 10.134; Classification
Cite this ruling
CBP Ruling W563169 (29349939): Protest AFR No. 3195-04-100142; Polypeptides; 9817.85.01 Prototype Treatment; Additional U.S. Rule of Interpretation 1(b); Actual Use; 19 CFR 10.134; Classification
Paste this into a product's override reason when citing this ruling as justification for a classification.
Other rulings for HS6 293499
The tariff classification of Etodolac (CAS-41340-25-4), Fenofibrate (CAS-49562-28-9), Flecainide Acetate (CAS-54143-56-5), and Fluvoxamine Maleate (CAS-61718-82-9) from Italy and Spain
The tariff classification of Etoxazole Technical (CAS-153233-91-1), imported in bulk form, from Japan
The tariff classification of Cytarabine (CAS-147-94-4), imported in bulk form, from Japan
The tariff classification of 4-Morpholinecarbonyl Chloride (CAS 15159-40-7) from China.
The tariff classification of Cyclophosphamide [CAS-6055-19-2; CAS-50-18-0 (anhydrous)], imported in bulk form, from Latvia